Neuropeptides 发表于 2025-3-25 05:56:59

http://reply.papertrans.cn/2/192/19164/19164-21.png

流眼泪 发表于 2025-3-25 11:24:00

Submitted on: 17 March 2004.
Revised on: 05 July 2004.
Accepted on: 25 August 2004.

___________________Journal of Risk Model Validation

寒冷 发表于 2025-3-25 12:25:19

http://reply.papertrans.cn/2/192/19164/19164-23.png

Crohns-disease 发表于 2025-3-25 19:04:10

http://reply.papertrans.cn/2/192/19164/19164-24.png

adj忧郁的 发表于 2025-3-25 23:55:46

http://reply.papertrans.cn/2/192/19164/19164-25.png

BROW 发表于 2025-3-26 00:36:06

Submitted on: 25 December 2021.
Revised on: 13 February 2022.
Accepted on: 12 March 2022.

___________________Journal of Risk Model Validation

撕裂皮肉 发表于 2025-3-26 04:32:53

http://reply.papertrans.cn/2/192/19164/19164-27.png

amygdala 发表于 2025-3-26 11:23:00

http://reply.papertrans.cn/2/192/19164/19164-28.png

INTER 发表于 2025-3-26 14:27:37

Submitted on: 25 March 2022.
Revised on: 02 July 2022.
Accepted on: 21 July 2022.

___________________Journal of Risk Model Validation

昏暗 发表于 2025-3-26 20:27:56

http://reply.papertrans.cn/2/192/19164/19164-30.png
页: 1 2 [3] 4
查看完整版本: SSCI期刊Journal of Risk Model Validation 2024/2025影响因子:0.442 (J RISK MODEL VALIDAT) (1753-9579). (BUSINESS, FINANCE)(商业、金